Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus

Candace M. Cham, Kichul Ko, Timothy B. Niewold

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple genetic risk factors, high levels of interferon alpha (IFN-α), and the production of autoantibodies against components of the cell nucleus. Interferon regulatory factor 5 (IRF5) is a transcription factor which induces the transcription of IFN-α and other cytokines, and genetic variants of IRF5 have been strongly linked to SLE pathogenesis. IRF5 functions downstream of Toll-like receptors and other microbial pattern-recognition receptors, and immune complexes made up of SLE-associated autoantibodies seem to function as a chronic endogenous stimulus to this pathway. In this paper, we discuss the physiologic role of IRF5 in immune defense and the ways in which IRF5 variants may contribute to the pathogenesis of human SLE. Recent data regarding the role of IRF5 in both serologic autoimmunity and the overproduction of IFN-α in human SLE are summarized. These data support a model in which SLE-risk variants of IRF5 participate in a feed-forward mechanism, predisposing to SLE-associated autoantibody formation, and subsequently facilitating IFN-α production downstream of Toll-like receptors stimulated by immune complexes composed of these autoantibodies.

Original languageEnglish (US)
Article number780436
JournalClinical and Developmental Immunology
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Interferon Regulatory Factors
Systemic Lupus Erythematosus
Interferon-alpha
Autoantibodies
Toll-Like Receptors
Antigen-Antibody Complex
Pattern Recognition Receptors
Cell Nucleus
Autoimmunity
Autoimmune Diseases
Transcription Factors
Cytokines

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. / Cham, Candace M.; Ko, Kichul; Niewold, Timothy B.

In: Clinical and Developmental Immunology, Vol. 2012, 780436, 2012.

Research output: Contribution to journalArticle

@article{7aafb1410c1d44da8b43f031329bfacc,
title = "Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus",
abstract = "Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple genetic risk factors, high levels of interferon alpha (IFN-α), and the production of autoantibodies against components of the cell nucleus. Interferon regulatory factor 5 (IRF5) is a transcription factor which induces the transcription of IFN-α and other cytokines, and genetic variants of IRF5 have been strongly linked to SLE pathogenesis. IRF5 functions downstream of Toll-like receptors and other microbial pattern-recognition receptors, and immune complexes made up of SLE-associated autoantibodies seem to function as a chronic endogenous stimulus to this pathway. In this paper, we discuss the physiologic role of IRF5 in immune defense and the ways in which IRF5 variants may contribute to the pathogenesis of human SLE. Recent data regarding the role of IRF5 in both serologic autoimmunity and the overproduction of IFN-α in human SLE are summarized. These data support a model in which SLE-risk variants of IRF5 participate in a feed-forward mechanism, predisposing to SLE-associated autoantibody formation, and subsequently facilitating IFN-α production downstream of Toll-like receptors stimulated by immune complexes composed of these autoantibodies.",
author = "Cham, {Candace M.} and Kichul Ko and Niewold, {Timothy B.}",
year = "2012",
doi = "10.1155/2012/780436",
language = "English (US)",
volume = "2012",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus

AU - Cham, Candace M.

AU - Ko, Kichul

AU - Niewold, Timothy B.

PY - 2012

Y1 - 2012

N2 - Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple genetic risk factors, high levels of interferon alpha (IFN-α), and the production of autoantibodies against components of the cell nucleus. Interferon regulatory factor 5 (IRF5) is a transcription factor which induces the transcription of IFN-α and other cytokines, and genetic variants of IRF5 have been strongly linked to SLE pathogenesis. IRF5 functions downstream of Toll-like receptors and other microbial pattern-recognition receptors, and immune complexes made up of SLE-associated autoantibodies seem to function as a chronic endogenous stimulus to this pathway. In this paper, we discuss the physiologic role of IRF5 in immune defense and the ways in which IRF5 variants may contribute to the pathogenesis of human SLE. Recent data regarding the role of IRF5 in both serologic autoimmunity and the overproduction of IFN-α in human SLE are summarized. These data support a model in which SLE-risk variants of IRF5 participate in a feed-forward mechanism, predisposing to SLE-associated autoantibody formation, and subsequently facilitating IFN-α production downstream of Toll-like receptors stimulated by immune complexes composed of these autoantibodies.

AB - Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple genetic risk factors, high levels of interferon alpha (IFN-α), and the production of autoantibodies against components of the cell nucleus. Interferon regulatory factor 5 (IRF5) is a transcription factor which induces the transcription of IFN-α and other cytokines, and genetic variants of IRF5 have been strongly linked to SLE pathogenesis. IRF5 functions downstream of Toll-like receptors and other microbial pattern-recognition receptors, and immune complexes made up of SLE-associated autoantibodies seem to function as a chronic endogenous stimulus to this pathway. In this paper, we discuss the physiologic role of IRF5 in immune defense and the ways in which IRF5 variants may contribute to the pathogenesis of human SLE. Recent data regarding the role of IRF5 in both serologic autoimmunity and the overproduction of IFN-α in human SLE are summarized. These data support a model in which SLE-risk variants of IRF5 participate in a feed-forward mechanism, predisposing to SLE-associated autoantibody formation, and subsequently facilitating IFN-α production downstream of Toll-like receptors stimulated by immune complexes composed of these autoantibodies.

UR - http://www.scopus.com/inward/record.url?scp=84870217929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870217929&partnerID=8YFLogxK

U2 - 10.1155/2012/780436

DO - 10.1155/2012/780436

M3 - Article

C2 - 23251221

AN - SCOPUS:84870217929

VL - 2012

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

M1 - 780436

ER -